lncRNA-mediated mechanisms of therapeutic resistance

No Pathway Network information available for lncRNA-mediated mechanisms of therapeutic resistance

Pathways in the lncRNA-mediated mechanisms of therapeutic resistance SuperPath

#	Name	Source	Genes
1	lncRNA-mediated mechanisms of therapeutic resistance	WikiPathways	ABCB1 BCL2L1 CDKN1A HIF1A TP53 WNT6 (see all 6) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	TP53	Tumor Protein P53	Protein Coding	1
2	BCL2L1	BCL2 Like 1	Protein Coding	1
3	ABCB1	ATP Binding Cassette Subfamily B Member 1	Protein Coding	1
4	HIF1A	Hypoxia Inducible Factor 1 Subunit Alpha	Protein Coding	1
5	CDKN1A	Cyclin Dependent Kinase Inhibitor 1A	Protein Coding	1
6	WNT6	Wnt Family Member 6	Protein Coding	1

Disorders associated with lncRNA-mediated mechanisms of therapeutic resistance SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Bladder cancer	Enrichment	CDKN1A, TP53	4.18
2	Colchicine resistance	Enrichment	ABCB1	3.35
3	Encephalopathy, acute transient	Enrichment	ABCB1	3.35
4	Bone marrow failure syndrome 5	Enrichment	TP53	3.35
5	Papilloma of choroid plexus	Enrichment	TP53	3.35
6	Basal cell carcinoma 7	Enrichment	TP53	3.35
7	Anaplastic thyroid carcinoma	Enrichment	TP53	3.35
8	Inflammatory bowel disease 13	Enrichment	ABCB1	3.35
9	Ductal carcinoma in situ	Enrichment	TP53	3.35
10	Thyroid gland undifferentiated carcinoma	Enrichment	TP53	3.35
11	Small-cell carcinoma of the ovary of hypercalcemic type	Enrichment	TP53	3.35
12	Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtype	Enrichment	TP53	3.35
13	Choroid plexus cancer	Enrichment	TP53	3.35
14	Pleomorphic xanthoastrocytoma	Enrichment	TP53	3.35
15	Adrenocortical carcinoma, hereditary	Enrichment	TP53	3.05
16	Cervical cancer	Enrichment	TP53	3.05
17	Lymphoma, hodgkin, classic	Enrichment	TP53	3.05
18	Congenital fibrosarcoma	Enrichment	TP53	3.05
19	Li-fraumeni syndrome 1	Enrichment	TP53	3.05
20	Sarcoma	Enrichment	TP53	3.05
21	Cervix carcinoma	Enrichment	TP53	3.05
22	Hodgkin's lymphoma	Enrichment	TP53	3.05
23	Pleomorphic rhabdomyosarcoma	Enrichment	TP53	3.05
24	Osteogenic sarcoma	Enrichment	TP53	2.88
25	Nasopharyngeal carcinoma	Enrichment	TP53	2.88
26	Atypical teratoid rhabdoid tumor	Enrichment	TP53	2.88
27	Anaplastic astrocytoma	Enrichment	TP53	2.88
28	Squamous cell carcinoma	Enrichment	TP53	2.88
29	Adenocarcinoma	Enrichment	TP53	2.88
30	Bone osteosarcoma	Enrichment	TP53	2.88
31	Enchondromatosis	Enrichment	HIF1A	2.88
32	Small cell cancer of the lung	Enrichment	TP53	2.75
33	Thyroid cancer, nonmedullary, 1	Enrichment	TP53	2.75
34	Lung sarcomatoid carcinoma	Enrichment	TP53	2.75
35	Embryonal rhabdomyosarcoma	Enrichment	TP53	2.75
36	Enchondromatosis, multiple, ollier type	Enrichment	HIF1A	2.66
37	Rhabdomyosarcoma 2	Enrichment	TP53	2.66
38	Lymphoma	Enrichment	TP53	2.66
39	Acute megakaryocytic leukemia	Enrichment	TP53	2.66
40	Li-fraumeni syndrome	Enrichment	TP53	2.58
41	Adrenocortical carcinoma	Enrichment	TP53	2.58
42	Breast adenocarcinoma	Enrichment	TP53	2.58
43	Esophageal cancer	Enrichment	TP53	2.51
44	Multiple endocrine neoplasia, type i	Enrichment	CDKN1A	2.51
45	Squamous cell carcinoma, head and neck	Enrichment	TP53	2.51
46	Multiple enchondromatosis, maffucci type	Enrichment	HIF1A	2.51
47	Essential thrombocythemia	Enrichment	TP53	2.51
48	Gallbladder cancer	Enrichment	TP53	2.51
49	B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)	Enrichment	TP53	2.51
50	Glioma susceptibility 1	Enrichment	TP53	2.45
51	Lymphoma, non-hodgkin, familial	Enrichment	TP53	2.45
52	Adult hepatocellular carcinoma	Enrichment	TP53	2.40
53	Primary hyperaldosteronism	Enrichment	TP53	2.40
54	Leukemia, chronic lymphocytic	Enrichment	TP53	2.35
55	Familial colorectal cancer	Enrichment	TP53	2.35
56	Epilepsy, idiopathic generalized	Enrichment	ABCB1	2.31
57	Myelodysplastic syndrome	Enrichment	TP53	2.31
58	Lip and oral cavity carcinoma	Enrichment	TP53	2.28
59	Lung cancer susceptibility 3	Enrichment	TP53	2.21
60	Rhabdomyosarcoma	Enrichment	TP53	2.15
61	Gliosarcoma	Enrichment	TP53	2.15
62	Giant cell glioblastoma	Enrichment	TP53	2.13
63	Diffuse large b-cell lymphoma	Enrichment	TP53	2.08
64	Hepatoblastoma	Enrichment	TP53	2.03
65	Hepatocellular carcinoma	Enrichment	TP53	2.01
66	Diamond-blackfan anemia 1	Enrichment	TP53	1.99
67	Pancreatic cancer	Enrichment	TP53	1.96
68	Prostate cancer	Enrichment	TP53	1.89
69	Diamond-blackfan anemia	Enrichment	TP53	1.80
70	Leukemia, acute myeloid	Enrichment	TP53	1.76
71	Gastric cancer	Enrichment	TP53	1.72
72	Hereditary breast carcinoma	Enrichment	TP53	1.71
73	Hereditary breast ovarian cancer syndrome	Enrichment	TP53	1.62
74	Myeloma, multiple	Enrichment	TP53	1.61
75	Breast cancer	Enrichment	TP53	1.49
76	Colorectal cancer	Enrichment	TP53	1.42
77	Ovarian cancer	Enrichment	TP53	1.36
78	Inherited cancer-predisposing syndrome	Enrichment	TP53	1.24

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

lncRNA-mediated mechanisms of therapeutic resistance

Pathway Network for lncRNA-mediated mechanisms of therapeutic resistance

Member Pathways for lncRNA-mediated mechanisms of therapeutic resistance

Pathways in the lncRNA-mediated mechanisms of therapeutic resistance SuperPath

Associated Genes for lncRNA-mediated mechanisms of therapeutic resistance

Associated Disorders for lncRNA-mediated mechanisms of therapeutic resistance

Disorders associated with lncRNA-mediated mechanisms of therapeutic resistance SuperPath

STRING Interaction Network for lncRNA-mediated mechanisms of therapeutic resistance

Sources for lncRNA-mediated mechanisms of therapeutic resistance